← Leaderboards
Betsy J Barnes
Univ Of Med/Dent Of Nj-Nj Medical School
$3,458,168
Attributed
$5,342,949
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,342,949 · 7
By mechanism
R01$3,308,938 · 1
R21$1,639,281 · 4
R03$394,730 · 2
Top collaborators
- Jessica A Hamerman6 shared
- Luca Giliberto2 shared
Most similar at Univ Of Med/Dent Of Nj-Nj Medical School
Same institution · by research overlap
- Utz Herbig$5,510,821
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenesTranscription FactorCytokinePathogenesisInterferonsSignal TransductionIn VivoAutoimmune DiseasesAlzheimer&AposPathway InteractionsMouse ModelCessation Of LifeLinkInflammatoryKineticsNew Therapeutic TargetMediatingMolecularImmune ResponseChronicPathogenicityAcuteMonocyte
Grant awards (18)
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis$577,132
R01 · FY2023 · AR
Investigating monocyte dysfunction in Down Syndrome$383,657
R01 · FY2023 · AR
Implications for Speckled proteins 110 and 140 in adaptive immunity$167,500
R03 · FY2023 · TR · contact PI
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis$577,613
R01 · FY2022 · AR
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimerâs disease$209,375
R21 · FY2022 · AG
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis$571,447
R01 · FY2021 · AR
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimerâs disease$251,250
R21 · FY2021 · AG
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis$589,776
R01 · FY2020 · AR
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis$609,313
R01 · FY2019 · AR
Determining the function of IRF5 tumor suppressor in HCV pathogenesis$183,244
R21 · FY2016 · CA · contact PI
Identification of a new factor, interferon regulatory factor 5, that controls spontaneous mammary tumorigenesis$183,244
R21 · FY2016 · CA · contact PI
Determining the function of IRF5 tumor suppressor in HCV pathogenesis$219,893
R21 · FY2015 · CA · contact PI
Identification of a new factor, interferon regulatory factor 5, that controls spontaneous mammary tumorigenesis$207,495
R21 · FY2015 · CA · contact PI
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an$174,900
R21 · FY2015 · AR · contact PI
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an$209,880
R21 · FY2014 · AR · contact PI
ROLE OF IRF5 IN SLE PATHOGENESIS$73,985
R03 · FY2008 · AR · contact PI
ROLE OF IRF5 IN SLE PATHOGENESIS$75,495
R03 · FY2007 · AR · contact PI
ROLE OF IRF5 IN SLE PATHOGENESIS$77,750
R03 · FY2006 · AR · contact PI